Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,551Revenue (TTM) $M200Net Margin (%)-66.9Altman Z-Score1.1
Enterprise Value $M1,470EPS (TTM) $-1.1Operating Margin %-71.9Piotroski F-Score4
P/E(ttm)--Beneish M-Score-2.7Pre-tax Margin (%)-70.2Higher ROA y-yY
Price/Book2.910-y EBITDA Growth Rate %--Quick Ratio1.9Cash flow > EarningsY
Price/Sales7.75-y EBITDA Growth Rate %-45.5Current Ratio2.1Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-14.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-24.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M121ROIC % (ttm)-36.1Gross Margin Increase y-yY

Gurus Latest Trades with XON

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

XON is held by these investors:



XON: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Last Andrew J.COO 2017-11-13Buy2,000$12.16.2view
Gupta Vinita DDirector 2017-08-22Buy3,000$17.61-27.03view
SHAPIRO ROBERT BDirector 2017-08-22Buy2,850$17.5-26.57view
Last Andrew J.COO 2017-08-14Buy2,000$19.99-35.72view
Lehr Donald P.Chief Legal Officer 2017-08-11Buy1,094$18.33-29.9view
Perez Jeffrey ThomasSVP, IP Affairs 2017-08-11Buy1,000$17.89-28.17view
MITCHELL DEAN JDirector 2017-08-11Buy5,000$18.33-29.9view
KIRK RANDAL JCEO, 10% Owner 2017-08-11Buy132,625$18.85-31.83view
Nimrodi NirSVP-Corporate Development 2017-08-11Buy3,369$18.75-31.47view
KINDLER JEFFREY BDirector 2017-08-11Buy5,440$18.32-29.86view

Press Releases about XON :

Quarterly/Annual Reports about XON:

News about XON:

Articles On GuruFocus.com
ZIOPHARM to Present at the Stifel 2017 Healthcare Conference Nov 10 2017 
Intrexon to Present at the Stifel 2017 Healthcare Conference Nov 10 2017 
ZIOPHARM Oncology Reports Third Quarter 2017 Financial Results and Provides Update on Recent Activit Nov 06 2017 
ZIOPHARM Announces Four Presentation Abstracts at the 2017 Annual Meeting of the Society for Neuro-O Nov 06 2017 
ZIOPHARM Announces Five Abstracts Accepted for Presentation at the 2017 American Society of Hematolo Nov 01 2017 
Intrexon to Announce Third Quarter 2017 Financial Results on November 9th Nov 01 2017 
ZIOPHARM Oncology to Host Third-Quarter 2017 Financial Results and Corporate Update Conference Call Oct 26 2017 
Intrexon and Arch Pharmalabs Collaborate on Fermentative Production of an API to Replace Existing Pr Oct 23 2017 
Intrexon CEO to Participate in World Food Prize Leadership Panel on Global Hunger Oct 19 2017 
Intrexon Corporation Enters into $100 Million Preferred Stock Equity Facility Oct 16 2017 
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK